Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0RP1J
|
|||
| Drug Name |
PMID29334795-Compound-66
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
AAPA B.V
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C27H34N4O3
|
|||
| Canonical SMILES |
C1CC(C1)N2CCC(CC2)OC3=CC=C(C=C3)CN4CCN(CC4)C5=CC=CC6=C5OC(=O)N6
|
|||
| InChI |
1S/C27H34N4O3/c32-27-28-24-5-2-6-25(26(24)34-27)31-17-15-29(16-18-31)19-20-7-9-22(10-8-20)33-23-11-13-30(14-12-23)21-3-1-4-21/h2,5-10,21,23H,1,3-4,11-19H2,(H,28,32)
|
|||
| InChIKey |
MCJUAFCGICUNIN-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Progress in the development of histamine H3 receptor antagonists/inverse agonists: a patent review (2013-2017).Expert Opin Ther Pat. 2018 Mar;28(3):175-196. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.